Furthermore, transthyretin has a neuroprotective effect in Alzheimer’s disease [47,48], and the plasma levels of this protein can be used as a biomarker for osteoporosis in elderly subjects [49]. The gene discussed is TTR; the disease is Alzheimer disease.